RAFI KEVORKIAN: Open Payments
NPI 1124073630 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 7 payments from 6 companies in 2025. Trend: 2023 $98 · 2024 $49 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lilly USA, LLC | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: CAPLYTA, MOUNJARO, ELIQUIS, The Cologuard Plus Collection Kit, INGREZZA, Auvelity.
Industry payments across MO — which companies pay providers there.
